p53 Mutation in Squamous Cell Carcinomas from Psoriasis Patients Treated with Psoralen + UVA (PUVA)
Authors:
- Peter WolfPWPeter Wolf
- Lorenzo CerroniLCLorenzo Cerroni
- Honnavara N. AnanthaswamyHAHonnavara N. Ananthaswamy
- 1 August 1997
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 109 (2) , 238-243
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- PUVA, UVB, psoriasis, and nonmelanoma skin cancerJournal of the American Academy of Dermatology, 1993
- An approach to the treatment of moderate to severe psoriasis with rotational therapyJournal of the American Academy of Dermatology, 1993
- Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomasMolecular Carcinogenesis, 1991
- The prevalence of malignant tumors in patients with psoriasisJournal of the American Academy of Dermatology, 1990
- MONOFUNCTIONAL ANGULAR FUROCOUMARINS: SEQUENCE SPECIFICITY IN DNA HOTOBINDING OF 6,4,4'-TRIMETHYLANGELICIN and OTHER ANGELICINSPhotochemistry and Photobiology, 1989
- Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapiesJournal of the American Academy of Dermatology, 1988
- Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasisJournal of the American Academy of Dermatology, 1986
- PsoriasisJournal of the American Academy of Dermatology, 1984
- PHOTOCHEMISTRY AND PHOTOBIOLOGY OF PSORALENSPhotochemistry and Photobiology, 1979